Stories | Patient Daily

Community

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community

Patient Daily | Apr 24, 2023

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration

Patient Daily | Apr 24, 2023

Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023

+ Technology/Innovation

Patient Daily | Apr 24, 2023

Axtria And HealthVerity Announce Strategic Partnership To Enable Next-Gen Real-World Data, Analytics, And Campaign Optimization Solutions For Life Sciences Organizations

+ Technology/Innovation

Patient Daily | Apr 24, 2023

Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting

+ Technology/Innovation

Patient Daily | Apr 24, 2023

Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest

Patient Daily | Apr 24, 2023

Kaia Health Named As Top Digital Therapeutics Company by AVIA Marketplace

Trending

+ Pharmaceuticals

Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals

Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation